Hi Led,

I think what we are seeing is possibly the calm before the storm, Until we definatively hear a start date to dosing the betonmance trial in Europe or an FDA approval of phase 3 or an orphan indication or anything else, were going to have little volume IMO, I wonder when we might hear about another peer review publication which we have heard is coming or anything else,

Patience is a virtue with this stock, I will continue to add ltittle by little to my position as I feel that as soon as we start BEtonmace we will slowing start to rise in SP similar to the last ASSURE trial that move right up to $8 just before the release of the trial data

GTLA